Beyond Diagnostics Information

Beyond Diagnostics is a Swiss deep-tech (spinn-off Diabetes Center Berne) company pioneering a new way to prove medication quality. We develop patent pending point-of-care solutions that help verify whether sensitive medicines remain stable and effective under real-world conditions, from production to the patient’s hands. Our first focus is on insulin, a life-saving therapy for over 100 million people worldwide. But our vision goes beyond diabetes: we aim to safeguard the integrity of all fragile medicines used outside clinical settings. Supported by Innosuisse, Beyond Diagnostics is bringing medication quality to light empowering patients, clinicians, and partners to make treatment safer and more sustainable. Because medication quality should be as clear as clean water. #VisibleInsulin #INSPIRELab #DiabetesInnovation #PointOfCare #DeepTech